Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors
NCT01401504 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2014-06-11
Summary
A study to evaluate the safety and anti-tumor activity of ASP3026 in patients with advanced malignancies (solid tumors).
Conditions
Interventions
- DRUG
-
ASP3026
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
Countries
- Japan
More Related Trials
-
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
NCT01213160 ·Status: COMPLETED ·Phase: PHASE1
-
Japanese Phase I Study of AZD2014 in Advanced Solid Malignancies
NCT02398747 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies
NCT01353781 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label, Dose Escalation Phase I Study of AZD2281
NCT00572364 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ASD141
NCT06235437 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients
NCT00613652 ·Status: COMPLETED ·Phase: PHASE1
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
NCT05142592 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
NCT03355066 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of ASP1002 in Adults for Treatment of Solid Tumors
NCT05719558 ·Status: RECRUITING ·Phase: PHASE1
-
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
NCT03529526 ·Status: UNKNOWN ·Phase: PHASE1
-
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
NCT05037149 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Clinical Study of ASN-3186 in Patients with Advanced Solid Tumors
NCT06787950 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I/II Study of AST-001 in Subjects With Advanced Solid Tumors
NCT06245330 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
SMP-3124LP in Adults With Advanced Solid Tumors
NCT06526819 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Study in Patients With Solid Tumours
NCT00496028 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer
NCT01605916 ·Status: COMPLETED ·Phase: PHASE1
-
Study of ASTX029 in Subjects With Advanced Solid Tumors
NCT03520075 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Trial of TAS-114 in Combination With S-1
NCT02454062 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AS1411 in Advanced Solid Tumours
NCT00881244 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors
NCT01392924 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of E7050 in Subjects With Solid Tumors
NCT01428141 ·Status: COMPLETED ·Phase: PHASE1
-
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
NCT04644068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067
NCT05306132 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
NCT05867420 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of ASP2074 in Adults With Solid Tumors
NCT05646797 ·Status: TERMINATED ·Phase: PHASE1